Oxford Immune Algorithmics is a deep biotech company incubated by the University of Oxford. Our team is divided into five major overlapping working groups representing the breadth and width of our company core areas: AI & Computer Vision, Biomedicine, App and Cloud development, IoT Engineering and Market Innovation.
|
The cross-functional team consists of AI experts, medical leaders, pioneers in IoT and optical engineering at the forefront of science and technology able to tackle some of the most pressing human health challenges such as cancer, infection, antibiotic resistance and tropical diseases.
Meeting at our Headquarters in the city centre of Reading, UK
|
In addition to the following members we have a team of coders, testers, and IT developers.
|
Dr. Hector Zenil
Founder & CEO BSc in Mathematics (UNAM), Masters in Logic (ENS/Paris), PhD in Computer Science (Lille), PhD in Epistemology (Sorbonne). He has 20+ years experience in academia & industry in 6 countries from NASA Payload team member at MIT (Mars Gravity Biosatellite) to test health and behavioural effects of artificial microgravity on mammals to helping develop the factual answering AI engine behind Siri and Alexa reporting to WolframAlpha's CEO; publishing > 100 papers on symbolic AI as a Senior Researcher (faculty member) at the University of Oxford & as lab leader at the Unit of Computational Medicine at the Karolinska Institute (the institution that awards the Nobel Prize in Medicine or Physiology). He is also affiliated to the Alan Turing Institute based at the British Library in London in a position to contribute to policy making advising the UK government on next-gen AI for Nobel-like scientific discoveries. |
Dr. Jürgen Riedel
Co-founder, CTO and DPO PhD in Physics (Germany). He is an international data expert with over 25 years of working experience at major companies in two continents, as well as a researcher in complex systems, classical field theory, quantum gravity, boson stars, neuro-symbolic AI & cellular automata. His expertise spans from extensive knowledge of database systems, data migration, business intelligence, analytics, data science, data visualisation, data governance and compliance. He has credentials from the most prestigious courses on machine intelligence & deep learning (also applied to medicine and healthcare) and has worked for major corporations in the private banking, manufacturing, and energy companies such as UBS, Citibank, Volkswagen, Zalando, Munich RE, Eon and, most recently, Rabobank. |
Agostino Forcella
Chief Operating Officer Engineering background in advanced microelectronics with a Masters degree covering technical and commercial aspects of planning designing & launching electronic products with more than 30 years experience in a wide range of areas including manufacturing, telco, software & hardware development, testing, large IT infrastructure, business development, and large-scale organisational transformations to UK Government and private firms. He was the Programme Delivery Director at BT Global Services responsible for the transition of BT Spine to Health & Social Care Information Centre & for delivering new tests & training platforms to the NHS. |
Dr. Kourosh Saeb-Parsy
Chief Medical Officer MD & PhD in Neurosciences (Cambridge), NHS Consultant Transplant Surgeon, University Reader in Transplantation & Clinical Research Group Leader at the Department of Surgery at the University of Cambridge specialising in immunogenicity of regenerative cellular therapies. More than 15 years of experience in Industry with large corporations and startups, including biotech companies. He is the director of the Cambridge In Vivo Assessment Platform and the Cambridge Biorepository for Translational Medicine. He has over 50 papers published in top journals such as Nature, and Science. |
Kaye Ashley
Lead Biomedical Scientist Degree in Medical Technology, certified Biomedical Scientist at HCPC and BMS certified in the UK & at the American Society of Clinical Pathology in the U.S. Her main expertise is in biochemistry, haematology & blood transfusion. |
Dr. Santiago Hernández O.
Senior AI Researcher PhD in Mathematics and 6+ years experience in research programming and R&D, postdoctoral experience at the Unit of Computational Medicine at the Karolinska Institute. He designs neurosymbolic and implements new AI algorithms in application to cell biology. |
J. Santiago Zenil-Araiza
Control Applications Engineer Engineering degree in mechatronics, robotics and automation with experience in mechanical, & electronic engineering in Germany, working for multinationals such as Siemens, Schneider Electric, and SSI Schaefer. |
Dr. M. Elena Martínez-Pérez
Senior Computer Vision Scientist PhD in Computer Science (Imperial College), postdoctoral researcher at the École Nationale Supérieure des Telecommunications (Paris), she is a world renowned researcher in medical image processing, pattern recognition & computer vision. |
MD. Motin Sobuj
3D Modeller Engineer Mechanical Design Engineer with Masters studies and Solidworks Professional-CSWP certification in Mechanical Design. He has more than 5 years of experience in Product Design, ECAD, MCAD, from concept drawing to 3D modelling, & complete bill of materials for IoT products. |
Dr. Samir Khan
Market Access Strategist PhD in Pharmacology (Cambridge) with a Bill and Melinda Gates Trust Scholarship. Specialisation on the commercialisation and pricing-market access of technologies and medical devices within the global health market. Previously a Business development Lead for the Strategic and Industry Partnerships (SIP) initiative at Oxford AHSN. He has worked also for Ipsos and GfK in the past. |
Dr. Rafael G. González-Acuña
Senior Optical Engineer Industrial Physical Engineer with a Master's Degree in Optomechatronics and PhD in Nanotechnology. He is co-author of the solution to the problem of designing bi-aspheric single lenses free of spherical aberration widely covered by the world press. |
Dr. Florent Michel
AI Researcher PhD in in Theoretical and Mathematical Physics with seven years' experience in mathematical modelling. Expert in mathematical machine learning with applications ranging from fundamental science to real-world problems in finance and data analysis. Held a postdoctoral position at Durham University in the UK. |
Alessandro Falcone
Investor Strategist An international and multidisciplinary background in medicine and business with experience in the pharma industry at companies like GSK (Senior Director in R&D, London) and Novartis (Head of Strategy and Chief of Staff in Europe, Munich), and IQVIA among other international companies based in the UK, Germany, Italy and Singapore. In charge of technology investment; cell & gene therapy strategy. |
John Escreet
Cloud IT Architect Cloud architect, database Administrator and Application/DB Developer. Specialties: SQL Server, Cloud Infrastructure and Data Warehousing. SQL optimisation, performance tuning and BI stack specialist. Web Development, ASP, C#, Client Server Development. Proficient in SAN architecture and vmWare for SQL Server optimisation and build. |
|
Scientific Advisory Board (SAB)SAB members actively participate in the development and operation of OIA, they meet at least twice a month with company officials and they help design OIA's offerings, evaluate OIA's science and promote OIA's technology.
|